Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.19 USD | -2.08% | -1.14% | +38.03% |
May. 28 | CorMedix Shares Rise on Multiyear DefenCath Supply Deal | MT |
May. 28 | CorMedix Inc. Announces Commercial Agreement with Top Tier Dialysis Provider | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+38.03% | 291M | |
+19.29% | 80.67B | |
+13.63% | 9.17B | |
-15.14% | 4.86B | |
+46.88% | 4.55B | |
+15.70% | 4.34B | |
+10.89% | 2.38B | |
-27.88% | 2.2B | |
+15.73% | 2.1B | |
-43.02% | 1.86B |
- Stock Market
- Equities
- CRMD Stock
- News CorMedix Inc.
- RBC Initiates CorMedix at Outperform, Speculative Risk With $6 Price Target, Sees DefenCath 'More Likely Than Not to Be Approved'